UC San Diego HealthDrug Combination May Improve Impact of Immunotherapy in Head and Neck CancerUC San Diego HealthCheckpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in … Continue reading
Biotechnology Market Analysis By Application, By Technology And Segment Forecasts, 2014 – 2025Markets InsiderSupportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Develo… Continue reading
|
Approval of first US cancer gene therapy ‘a significant milestone …
Kankakee Daily Journal In an interview with The Washington Post on Monday, U.S. Food and Drug Administration Commissioner Scott Gottlieb said the medical and scientific community … |
Neurology Advisor |
Risk of Stroke, Mortality Reduced With High Stem Cell Factor
Neurology Advisor HealthDay News — High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published in the Journal of Internal Medicine. Harry Björkbacka, PhD, from Lund University in Sweden … |
|
New Project Will Explore Gene Therapies in Hemophilia Treatments
AJMC.com Managed Markets Network The CoreHEM strives to develop a “core set” of outcomes to calculate gene therapy effectiveness by combing ideas form clinicians, researchers, patients, product manufacturers, public and private payers, and international government agencies. |